Emcitate ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
78Hypopituitarism2

78. Hypopituitarism


Clinical trials : 494 Drugs : 385 - (DrugBank : 49) / Drug target genes : 44 - Drug target pathways : 100
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2019-003370-35-IT
(EUCTR)
30/04/202024/05/2021Tiratricol treatment of children with Monocarboxylate Transporter 8 deficiency: Triac Trial IITiratricol treatment of children with Monocarboxylate Transporter 8 deficiency: Triac Trial II - Triac Trial II Monocarboxylate Transporter 8 (MCT8) deficiency
MedDRA version: 20.0;Level: PT;Classification code 10078564;Term: Thyroid stimulating hormone deficiency;System Organ Class: 10014698 - Endocrine disorders;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
Product Name: emcitate
Product Code: [emcitate]
INN or Proposed INN: Tiratricol
Other descriptive name: Tiratricol
Product Name: Emcitate
Product Code: [Emcitate]
INN or Proposed INN: Tiratricol
Other descriptive name: Tiratricol
Rare Thyroid Therapeutics InternationalNULLAuthorised-recruitment may be ongoing or finishedFemale: no
Male: yes
18Phase 2France;United States;Czechia;Czech Republic;Netherlands;Germany;United Kingdom;Italy
2EUCTR2019-003370-35-GB
(EUCTR)
28/02/202007/01/2020Tiratricol treatment of children with Monocarboxylate Transporter 8 deficiency: Triac Trial IITiratricol treatment of children with Monocarboxylate Transporter 8 deficiency: Triac Trial II - Triac Trial II Monocarboxylate Transporter 8 (MCT8) deficiency
MedDRA version: 20.0;Level: PT;Classification code 10078564;Term: Thyroid stimulating hormone deficiency;System Organ Class: 10014698 - Endocrine disorders;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
Product Name: Emcitate
INN or Proposed INN: TIRATRICOL
Product Name: Emcitate
INN or Proposed INN: TIRATRICOL
Rare Thyroid Therapeutics International ABNULLAuthorised-recruitment may be ongoing or finishedFemale: no
Male: yes
22Phase 2United States;France;Czech Republic;Netherlands;Germany;Italy;United Kingdom